PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 69 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $115,251 | +1.1% | 22,822 | +0.7% | 0.00% | 0.0% |
Q2 2023 | $113,970 | -1.3% | 22,658 | +20.7% | 0.00% | 0.0% |
Q1 2023 | $115,485 | -54.8% | 18,778 | -3.0% | 0.00% | -50.0% |
Q4 2022 | $255,644 | +41.2% | 19,367 | -33.7% | 0.00% | 0.0% |
Q1 2022 | $181,000 | -32.2% | 29,221 | -11.2% | 0.00% | -33.3% |
Q4 2021 | $267,000 | – | 32,906 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
tru Independence LLC | 500 | $0 | 0.00% |
Renaissance Technologies | 120,269 | $319,000 | 0.00% |
D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |